bioRxiv · 10.1101/2020.07.15.203331
Erythrocyte-targeted immunomodulatory antigens enabled by in vivo selection of D-peptides
Abstract
Targeting of antigens to erythrocytes can be used to selectively mitigate their immunogenicity, but the methods to equip a variety of cargoes with erythrocyte-targeting properties are limited. Here we identified a D-peptide that targets murine erythrocytes and decreases anti-drug antibody responses when conjugated to the protective antigen from Bacillus anthracis, a protein of therapeutic interest. The D-peptide likewise decreases inflammatory anti-ovalbumin (OVA) CD8+ T cell responses when attached to a peptide antigen derived from OVA. To discover this targeting ligand, we leveraged mass spectrometry to decode a randomized D-peptide library selected in mice, extending the application of synthetic libraries to in vivo affinity selections.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Loftis, A. R., Zhang, G., Backlund, C., Quartararo, A. J., Pishesha, N., Schissel, C. K., Garafola, D., Loas, A., Collier, R. J., Ploegh, H., Irvine, D. J., Pentelute, B. L.. 2020-07-15. Erythrocyte-targeted immunomodulatory antigens enabled by in vivo selection of D-peptides. https://doi.org/10.1101/2020.07.15.203331
Cite the original work for its findings. Save a collection to share your selection of sources.